Kenneth Allen Myszkowski, Chief Financial Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 163,750 shares at $14.55 ($2.4M) on 2019-01-17, disclosed to the SEC on 2019-01-18.
Seasonal sale ($2.4M) by Chief Financial Officer — this insider has traded ARWR in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.55 | 81,875 | $1.2M | 50.0% |
| 2 | $14.55 | 81,875 | $1.2M | 50.0% |
| Total | $14.55 avg | 163,750 | $2.4M | 100% |
| Filing → |
| ARWR | SELL | 2024-01-08 | $885K | — | Filing → |
| ARWR | SELL | 2023-06-29 | $543K | — | Filing → |
| ARWR | SELL | 2022-12-30 | $1.2M | — | Filing → |